Background & Purpose

Global events have exposed vulnerabilities in Europe's medicine supply chains, prompting the EU Commission to propose a new regulation. However, Sweden questions whether the EU should control national planning, permits, and environmental reviews.

The Decision

Riksdagen beslutar att lämna ett motiverat yttrande till EU.

Does this affect you?

  • National authorities handling permits: Retains the responsibility for managing national planning, building, and environmental permit processes without EU interference in these specific areas.
  • Healthcare sector stakeholders: Affected by how the EU and Sweden eventually secure the supply chain of critical medicines.

In Practice

  • Sweden reviews the EU Commission proposal regarding critical medicines.
  • Parliament identifies parts of the proposal that interfere too much with national authority.
  • An official reasoned opinion is submitted to the leaders of the European Parliament, the Council, and the Commission.